Cold Agglutinin Disease (CAD) in the Clinic: Recognizing and addressing the impact of CAD beyond anemia - European Medical Journal

Cold Agglutinin Disease (CAD) in the Clinic: Recognizing and addressing the impact of CAD beyond anemia

Hematology

This satellite symposium was organised and sponsored by Sanofi and is intended for healthcare professionals only. Speakers were compensated for their participation at this event.


Watch this EHA2024 Satelite Symposium exploring the disease burden of CAD beyond anemia by examining its influence on day-to-day life and its effects on long-term health.

Sections:

  • CAD animation video – 00:00–01:46
  • Introduction (Joan Cid) – 01:46–04:43
  • Practicalities of diagnosing CAD and understanding patient burden (Bernd Jilma) – 04:43–19:01
  • Addressing the long-term impact of CAD beyond anemia (Bruno Fattizzo) – 19:01–36:00
  • Adding value with the Cold Agglutinin Disease Real-World Evidence (CADENCE) Registry: Optimizing real-world data collection (Joan Cid) – 36:00–46:17

Faculty:

Joan Cid
MD, PhD (Chair), Clinic Barcelona, Barcelona, Spain

Bernd Jilma
MD, Medical University, of Vienna, Austria

Bruno Fattizzo
MD, Fondazione IRCCS, Ca’Granda Ospedale, Maggiore Poloclinico, Milan, Italy

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.